MedTrace Logo

Comparison Efficacy in Patients With Asthma Using Foster MDI and Relvar Medications

NCT04185129 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2019-12-04

No results posted yet for this study

Summary

This is a randomized study to compare asthma patients using Foster or Relvar.

Conditions

Interventions

DRUG

Foster

a randomized study for comparison asthma patients using Foster or Relvar. The primary end point is lung function improvement evaluation

Sponsors & Collaborators

  • Orient Europharma Co., Ltd.

    collaborator INDUSTRY

  • Far Eastern Memorial Hospital

    lead OTHER

Principal Investigators

  • Shih-Lung Cheng · Far Eastern Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-12-31
Completion
2022-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04185129 on ClinicalTrials.gov